Clinical Trial Update: N-ACetylcysteine to Reduce Infection and Mortality for Alcoholic Hepatitis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating N-acetylcysteine to reduce infection and mortality in alcoholic hepatitis is reported as an update with unknown current status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcoholic Hepatitis
• Infection

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: Imperial College London | Conditions: Alcoholic Hepatitis, Infection | Phase 3 | Status: UNKNOWN